Drug-labels.com

Ropinirole (Cobalt Pharmaceuticals): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
0.25 mg, 1 mg, 2 mg, 5 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Ropinirole (Cobalt Pharmaceuticals)

ABOUT THIS MEDICATION

What the medication is used for:

ROPINIROLE, also known as ropinirole is used to treat the signs and symptoms of Parkinson’s disease.

You may receive ROPINIROLE on its own, but it may also be given with another drug used to treat Parkinson’s disease.

What it does:

ROPINIROLE belongs to the family of medicines called dopamine agonists. ROPINIROLE improves some of the chemical imbalance in the part of the brain affected by Parkinson’s disease.

When it should not be used:

Do not use ROPINIROLE if you are allergic to it or any of the components of its formulation (see list below). ROPINIROLE is not recommended for children under 18 years of age.

What the medicinal ingredient is:

Ropinirole hydrochloride

What the nonmedicinal ingredients are:

Non-medicinal ingredients include: croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, FD&C Blue #2 (1mg and 2mg), iron oxide yellow (1mg, 2mg and 5mg), FD&C yellow #6 (2mg), iron oxide red (5mg) and iron oxide black (5mg)

What dosage forms it comes in:

ROPINIROLE is available as 0.25 mg (white), 1 mg (green), 2 mg (pink) and 5 mg (blue) tablets.

WARNINGS AND PRECAUTIONS

You are warned of a sudden onset of sleep condition which may occur without warning, while taking ROPINIROLE. You should not operate machinery or engage in activities that require alertness, as you may put yourself and others at risk of serious injury or death. This sudden onset of sleep condition has also been reported in patients taking other similar anti-Parkinson drugs.

What should I know before taking ROPINIROLE:

Studies of people with Parkinson’s disease show that they may be at an increased risk of developing melanoma, a form of skin cancer, when compared to people without Parkinson’s disease. It is not known if this problem is associated with Parkinson’s disease or the drugs used to treat Parkinson’s disease. ROPINIROLE is one of the drugs used to treat Parkinson’s disease, therefore, patients treated with ropinirole should have periodic skin examinations.

Drop in Blood Pressure

While taking ROPINIROLE you may experience a drop in blood pressure that may make you feel dizzy or faint especially when standing up from a sitting or lying position.

Neurological Disorder

Symptoms resembling a neurological disorder (Neuroleptic Malignant Syndrome) characterized by fever, muscle stiffness, stupor and unstable involuntary actions have been reported in relation to changes in treatment, reduction of treatment dose and stopping treatment,

ROPINIROLE taken with L-dopa

ROPINIROLE may amplify the side effects of L-dopa (also called levodopa) and may cause or worsen pre-existing uncontrolled jerky movements (dyskinesia).Tell your doctor if this happens as the dose of your medicines may need adjusting.

Eye Disorders

If you have albinism (lack of pigment at ion in skin or hair), you may have an increased risk of eye disorders while taking ROPINIROLE compared to people without albinism. Therefore, you should take ROPINIROLE only under an ophthalmologist’s (doctor who specializes in eye disorders) care.

Hallucinations

While taking ROPINIROLE, you may experience hallucinations, such as seeing or hearing things that aren’t really there.

Psychiatric Disorders

Impulse control symptoms including compulsive behaviours, e.g. feeling an urge to gamble, hypersexuality, compulsive shopping, or binge eating, as well as aggression have been reported with the use of ROPINIROLE.

BEFORE you use ROPINIROLE talk to your doctor or pharmacist if you:

  • have any health problem, especially any heart, liver or kidney condition.
  • have previously taken ropinirole and became unwell.
  • have any allergies or reactions to foods or drugs.
  • are pregnant or think you may be pregnant, or if you are breast feeding. You should not be taking Ropinirole if you are pregnant or breast feeding.

  • are taking any other medications, including any drugs you can buy without a prescription.
  • have experienced any unusual urges and/or behaviours (such as excessive gambling or excessive sexual behaviour). (See SIDE EFFECTS AND WHAT TO DO ABOUT THEM)

INTERACTIONS WITH THIS MEDICATION

Other medications may be affected by ROPINIROLE or may affect how ROPINIROLE works. Do not take any other medication, including any drugs or herbal products you can buy without a prescription. Tell any other doctor, dentist or pharmacist that you talk to that you are taking ROPINIROLE.

Drug-drug Interaction:

Drugs that may interact with ROPINIROLE include:

  • a drug used to help with breathing difficulties called

    theophylline

  • an antibiotic called ciprofloxacin
  • any hormone replacement therapy (HRT)
  • other dopamine agonists, e.g. L-dopa: ROPINIROLE

    may make some of the side effects of L-dopa worse, e.g. jerky movement.

  • certain medicines called neuroleptics used to treat

    schizophrenia and other serious mental illnesses

  • digoxin, a heart medicine that is used to treat congestive

    heart failure or certain heartbeat irregularities

Drug-lifestyle Interaction:

  • ROPINIROLE may affect your ability to remain alert

    while doing normal daily activities. You should refrain yourself from doing activities such as driving a car doing physical tasks or using hazardous machinery until you know how ROPINIROLE affects you.

  • Because ROPINIROLE can make you feel sleepy, tell

    your doctor or pharmacist if you are planning to drink alcohol.

Before making any change to other medications you are taking, or stopping them, talk to your doctor first.

PROPER USE OF THIS MEDICATION

Usual dose:

Follow the doctor’s instructions about how and when you should

take your tablets. Your doctor will decide how many tablets you need to take each day and you should always follow his/her instructions. When you first start taking ROPINIROLE, the amount you take will be increased gradually.

Your doctor may adjust the amount that you are taking. You will usually be told to take ROPINIROLE three times a day. You should not change the dose or discontinue treatment with ROPINIROLE without the recommendation of your doctor.

If you are taking other medicines for Parkinson’s disease, the doctor may adjust the dose of these medicines while you are taking ROPINIROLE.

You should swallow the tablets whole with water. Do not chew. ROPINIROLE can be taken with or without food.

You should continue to take your medicine even if you do not feel better, as it may take a number of weeks for the medicine to work.

REMEMBER: THIS MEDICINE IS FOR THE PERSON NAMED BY THE DOCTOR. DO NOT GIVE IT TO ANYBODY ELSE.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

If you or someone you know have taken too many tablets all at once, you should get medical help immediately, either by calling your doctor, the Regional Poison Control Centre, or the nearest hospital (do not drive yourself). Always take the labelled medicine container with you even if there are no tablets left.

Missed Dose:

If you have forgotten to take ROPINIROLE, do not take extra doses to make up for the forgotten individual doses. When you do remember to take ROPINIROLE, take your next dose of ROPINIROLE at the usual time. If you have missed taking ROPINIROLE for one day or more consult your doctor for advice on restarting ROPINIROLE.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medications, ROPINIROLE tablets can cause some side effects. You may not experience any of them. For most patients these side effects are likely to be minor and temporary. However, some may be serious. Consult your doctor if you experience these or other side effects.

Some of the most commonly reported side effects of ropinirole tablets are:

  • Feeling or being sick
  • Stomach ache
  • Dizziness or light-headedness, fainting
  • Sleepiness
  • Headache
  • Some leg swelling
  • Tiredness
  • Viral infection
  • Feeling full and bloated or experiencing heartburn
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your doctor or pharmacist

right away

Stop taking drug and seek

immediate emergency assistance

Only if severeIn all cases

Very

Common

Uncontrollable movements (dyskinesias)√
CommonHallucinations, feeling confused√
Uncommon

Having severe confusion,

irrational ideas or feeling irrational suspiciousness, other psychotic reactions, impulse control (symptoms like increased libido, feeling the urge to gamble, to shop or eat, acting in an aggressive manner)

√
Very rare

Allergic reactions (symptoms like red, itchy

swellings on the skin, swelling of the face, lips, mouth, tongue or throat, difficulty swallowing or breathing, rash or intense itching)

√

Extreme

sleepiness,

falling asleep without warning

√

This is not a complete list of side effects. For any unexpected effects while taking ROPINIROLE, contact your doctor or pharmacist.

HOW TO STORE IT

The expiry date of this medicine is printed on the label. Do not use the medicine after this date.

Keep your tablets in their original pack in a dry place away from

light and moisture. They should be kept at room temperature (between 15 to 30°C). Close container tightly after each use.

Keep out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

----------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the
management of side effects, contact your health professional.
The Canada Vigilance Program does not provide medical
advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Cobalt Pharmaceuticals Company, at: 1-866-254-6111.

Cobalt Pharmaceuticals Company

6733 Mississauga Road

Mississauga, ON

L5N 6J5

Last revised: September 4, 2014

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02345129

Revision date stated in the text: September 4, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ropinirole (Cobalt Pharmaceuticals)

Rx or OTC
Prescription (Rx)?
DIN 02345129, 02345137, 02345145, 02345153
Schedule(s) PRESCRIPTION
Active ingredient(s) Ropinirole (ropinirole hydrochloride)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N04 Anti-parkinson drugs
      1. N04B Dopaminergic agents
        1. N04BC Dopamine agonists
          1. N04BC04 Ropinirole
Company COBALT PHARMACEUTICALS COMPANY
Current status Cancelled Pre Market
Current status date September 1, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02345129 0.25 MG Tablet Cancelled Pre Market September 1, 2017
02345137 1 MG Tablet Cancelled Pre Market September 1, 2017
02345145 2 MG Tablet Cancelled Pre Market September 1, 2017
02345153 5 MG Tablet Cancelled Pre Market September 1, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.